HIV Infection, Cocaine Use and Coronary Artery Disease in HIV+ African Americans

HIV 感染、可卡因使用和 HIV 非洲裔美国人的冠状动脉疾病

• 批准号: 7883687
• 负责人: SHENGHAN LAI
• 金额: $ 75.09万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-30 至 2013-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7883687
• 关键词: AIDS/HIV problem; Address; Adverse effects; Affect; African American; Age; American; Ammonia; Arterial Fatty Streak; Atherosclerosis; Blood Pressure; Blood Vessels; CCR5 gene; Calcified; Cardiovascular system; Coagulation Process; Cocaine Dependence; Cocaine Users; Coronary; Coronary Arteriosclerosis; Coronary Stenosis; Coronary artery; Development; Endothelium; Event; Functional disorder; Generations; Growth Factor; HIV; HIV Infections; Heart Diseases; Image; Imaging technology; Immunologic Factors; Incidence; Individual; Inflammation; Integrase Inhibitors; Laboratories; Lead; Left; Left Ventricular Dysfunction; Lesion; Long-Term Effects; Longitudinal Studies; Measures; Metabolic; Monocyte Chemoattractant Protein-1; Myocardial Infarction; Nitric Oxide; Nitrogen; Obstruction; PET/CT scan; Persons; Platelet Activation; Platelet-Derived Growth Factor; Population; Prevalence; Prevention; Preventive Intervention; Protease Inhibitor; Race; Randomized Clinical Trials; Reporting; Research; Risk; Risk Factors; Rupture; Selectins; Severities; Staging; Stenosis; Sum; Testing; Translations; Tumor Necrosis Factor-alpha; Tumor Necrosis Factors; VWF gene; Ventricular; Viral Load result; Vulnerable Populations; antiretroviral therapy; base; cardiovascular risk factor; clinical application; cocaine use; cohort; cytokine; immune activation; in vivo; inhibitor/antagonist; normotensive; premature; public health relevance; sex; sudden cardiac death; von Willebrand Factor

DESCRIPTION (provided by applicant): African Americans (AAs) in the US are greatly over-represented not only among persons affected by HIV/AIDS and cocaine addiction, but also among persons affected by coronary artery disease (CAD) associated with HIV infection, antiretroviral therapy (ART), and cocaine use. According to our preliminary study, the rate of presence of coronary plaques/stenosis was disturbingly high in HIV-infected cardiovascularly asymptomatic AAs (27%). The rate was even higher in those who were long-term ART users or long-term cocaine users. Thus, it is critical to estimate the prevalence and incidence of coronary plaques and coronary luminal obstruction caused by both calcified and noncalcified plaques in that participating population and to examine the risk factors for coronary plaques and coronary luminal obstruction in HIV-infected cardiovascularly asymptomatic AAs. Also, since there is only a limited understanding of the mechanisms involved in the development of premature CAD in HIV-infected persons, a mechanistic study in vivo is proposed with the use of endothelial dysfunction markers and the most advanced imaging technologies to quantify coronary endothelial dysfunction - the earliest stage of atherosclerosis. The proposed specific aims are (1) To estimate the prevalence and incidence of metabolic and anthropometric abnormalities, coronary plaques, significant coronary stenoses, and left ventricular (LV) dysfunction; (2) To examine the effects of the severity of HIV infection, as measured by HIV viral load and CD4 nadir, on the presence and development of significant coronary stenoses, coronary plaques, plaque composition, and LV dysfunction; (3) To examine the effects of long-term ART (all classes), especially PI-based ART, on the presence and development of significant coronary stenoses, coronary plaques, plaque composition, and LV dysfunction; (4) To examine how cocaine use modifies the effects of the various classes of ART on the presence and development of significant coronary stenoses, coronary plaques, plaque composition, and LV dysfunction; (5) To longitudinally examine the risk factors for cardiovascular events in HIV-infected AAs with coronary plaques and significant coronary stenoses; (6) To investigate the direct effects and mechanisms of HIV infection, ART use, and cocaine use on endothelial dysfunction, as measured by endothelium-derived markers; and (7) To assess the direct effects and mechanisms of HIV infection, ART use, and cocaine use on coronary endothelial dysfunction, as measured with the use of N-13-ammonia PET/CT imaging. This study could provide critical information for understanding the mechanisms of premature CAD and lead to a breakthrough in research on prevention/intervention of CAD in HIV-infected persons and to translation of scientific discoveries into clinical applications. PUBLIC HEALTH RELEVANCE: This study will investigate why HIV-infected African Americans have high rates of heart disease. The study could provide critical information for understanding the mechanisms of premature heart disease and lead to a breakthrough in research on prevention/intervention of heart disease in HIV-infected persons and to translation of scientific discoveries into clinical applications.

描述（由申请人提供）：在美国，非裔美国人（AAs）不仅在受艾滋病毒/艾滋病和可卡因成瘾影响的人群中，而且在受与艾滋病毒感染、抗逆转录病毒治疗（ART）和可卡因使用相关的冠状动脉疾病（CAD）影响的人群中，所占比例大大过高。根据我们的初步研究，在hiv感染的心血管无症状AAs中，冠状动脉斑块/狭窄的发生率高得令人不安（27%）。在长期抗逆转录病毒疗法使用者或长期可卡因使用者中，这一比例甚至更高。因此，评估参与人群中由钙化斑块和非钙化斑块引起的冠状动脉斑块和冠脉管腔阻塞的患病率和发病率，以及检查hiv感染的心血管无症状AAs中冠状动脉斑块和冠脉管腔阻塞的危险因素至关重要。此外，由于对hiv感染者早期CAD发展的机制了解有限，因此提出了一项体内机制研究，使用内皮功能障碍标志物和最先进的成像技术来量化冠状动脉内皮功能障碍-动脉粥样硬化的最早阶段。提出的具体目的是：(1)估计代谢和人体测量异常、冠状动脉斑块、显著冠状动脉狭窄和左心室功能障碍的患病率和发生率；(2)通过HIV病毒载量和CD4最低点来检测HIV感染严重程度对显著冠状动脉狭窄、冠状动脉斑块、斑块组成和左室功能障碍的存在和发展的影响；(3)检查长期ART（所有类别），特别是基于pi的ART对显著冠状动脉狭窄、冠状动脉斑块、斑块组成和左室功能障碍的存在和发展的影响；(4)研究可卡因的使用如何改变不同类型抗逆转录病毒药物对显著冠状动脉狭窄、冠状动脉斑块、斑块组成和左室功能障碍的存在和发展的影响；(5)纵向检查合并冠状动脉斑块和明显冠状动脉狭窄的hiv感染AAs心血管事件的危险因素；(6)研究HIV感染、抗逆转录病毒治疗和可卡因使用对内皮功能障碍的直接影响和机制，通过内皮衍生标志物测量；(7)通过n -13-氨PET/CT成像来评估HIV感染、ART使用和可卡因使用对冠状动脉内皮功能障碍的直接影响和机制。本研究为了解早发性CAD的发病机制提供了重要信息，为hiv感染者预防/干预CAD的研究带来突破，并将科学发现转化为临床应用。公共卫生相关性：这项研究将调查为什么感染艾滋病毒的非裔美国人心脏病发病率高。这项研究可以为了解早发性心脏病的机制提供重要信息，并导致艾滋病毒感染者心脏病预防/干预研究的突破，并将科学发现转化为临床应用。